Mersana Therapeutics Inc (NASDAQ:MRSN) currently has a daily average trading volume of 1.12M but it saw 1675931 shares traded in last market. With a market cap of 250.25M USD, the company’s current market price of $2.04 came rising about 11.48 while comparing to the previous closing price of $1.83. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.28 and as low as $1.07. In the recent trading on the day, stock has struck highest price mark of $1.8 while lowest mark touched by it was $2.18.
Taking a look at 20-day trading activity of Mersana Therapeutics Inc (MRSN) gives us an average price of $1.8500, while its current price level is -67.52% below from 52-week high level whereas it is 91.55% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.6900 while that of 200 days or SMA-200 reads an average of $2.8100. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.33% during that period while stretching the period over a month that increases to 10.01%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 59.27 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the JP Morgan which upgraded the stock as “Neutral” in its note to investors issued on March 19, 2024, recommending a price target of $5 for it. Wedbush upgraded its recommendation for the stock as a “Outperform” from “Neutral” on February 29, 2024 while assigning a price target range of $2-$7. Guggenheim also issued its recommendations for the stock as it upgraded the price target for the stock is $7.
Over the week, MRSN’s stock price is moving 13.33% up while it is 40.69% when we observe its performance for the past one month. Year-to-date it is -12.07% down and over the past year, the stock is showing an upside performance of 61.90%.
Currently, Mersana Therapeutics Inc’s total number of outstanding shares is 120.71M. Company’s return on investment (ROI) stands at -364.47% and return on equity (ROE) at -213.33%. Stock’s beta reads 1.47. Stock has a price to book (P/B) ratio of 29.70 while price to sale or P/S ratio amounts to 8.36. Its return on asset (ROA) is -42.75% on average.
